CR20140461A - VEGF SPECIFIC ANTAGONISTS - Google Patents

VEGF SPECIFIC ANTAGONISTS

Info

Publication number
CR20140461A
CR20140461A CR20140461A CR20140461A CR20140461A CR 20140461 A CR20140461 A CR 20140461A CR 20140461 A CR20140461 A CR 20140461A CR 20140461 A CR20140461 A CR 20140461A CR 20140461 A CR20140461 A CR 20140461A
Authority
CR
Costa Rica
Prior art keywords
specific antagonists
vegf specific
vegf
antagonists
disclosed
Prior art date
Application number
CR20140461A
Other languages
Spanish (es)
Inventor
Napoleone Ferrara
Nina Korsisaari
Robert D Mass
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40261601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20140461(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2007/088000 external-priority patent/WO2008077077A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CR20140461A publication Critical patent/CR20140461A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se divulgan métodos de tratamiento de tumores benignos precancerosos o no metastásicos usando un antagonista específico anti-VEGF.Methods of treating benign precancerous or non-metastatic tumors using a specific anti-VEGF antagonist are disclosed.

CR20140461A 2006-12-19 2014-10-01 VEGF SPECIFIC ANTAGONISTS CR20140461A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87074506P 2006-12-19 2006-12-19
US87074106P 2006-12-19 2006-12-19
US87726706P 2006-12-27 2006-12-27
PCT/US2007/088000 WO2008077077A2 (en) 2006-12-19 2007-12-18 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors

Publications (1)

Publication Number Publication Date
CR20140461A true CR20140461A (en) 2014-10-28

Family

ID=40261601

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140461A CR20140461A (en) 2006-12-19 2014-10-01 VEGF SPECIFIC ANTAGONISTS

Country Status (2)

Country Link
CL (1) CL2007003712A1 (en)
CR (1) CR20140461A (en)

Also Published As

Publication number Publication date
CL2007003712A1 (en) 2008-06-20

Similar Documents

Publication Publication Date Title
ATE554769T1 (en) MEDIUM-DURING NEUROMUSCULAR BLOCKERS AND ANTAGONISTS ADVON
EA201170636A1 (en) Antagonists of toll-like receptor 3
AR064458A1 (en) VEGF SPECIFIC ANTAGONISTS FOR ADJUTIVE AND NEOADJUTIVE THERAPY AND TUMOR TREATMENT IN EARLY STAYS
ATE524467T1 (en) NOVEL AZA HETEROCYCLES AS KINASE INHIBITORS
EA201070856A1 (en) CRYSTAL FORMS OF DIMETOXIDOCETAXELA AND METHODS FOR THEIR RECEPTION
EA200870410A1 (en) Antagonists kinases
BRPI0922224A2 (en) receptor protein tyrosine kinase inhibitor compositions.
ATE469895T1 (en) CGRP RECEPTOR ANTAGONISTS
BRPI0605921A2 (en) organic compounds
ATE493411T1 (en) PYRROLOÄ2, 3-BÜPYRIDINE-4-YL-BENZENESULFONAMIDE COMPOUNDS AS IKK2 INHIBITORS
EA200870029A1 (en) METHOD OF APPLICATION OF IL-6 ANTAGONISTS WITH PROTEAS INHIBITORS
ATE496051T1 (en) PYRAZOLOTETRAHYDROPYRIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
DK2505204T3 (en) Method for Treating Prostate Cancer with the GnRH Antagonist Degarelix
BRPI0506679A (en) Methods of Treating Osteoarthritis with IL-6 Antagonists
NL2000397C2 (en) Bicyclic heteroaryl compounds as PDE10 inhibitors.
MX354402B (en) Small molecule inhibitors of the pleckstrin homology domain and methods for using same.
ATE478064T1 (en) PYRIMIDINE DERIVATIVES USED AS PI-3-KINASE INHIBITORS
DK2211180T3 (en) Use of protein SATB2 as a marker to distinguish colorectal cancer from other cancers
AU2011278832A8 (en) Novel fused heterocyclic derivatives useful as c-Met tyrosine kinase inhibitors
EA201071234A1 (en) IZOHINOLINON DERIVATIVES AS NK3 ANTAGONISTS
DK1984345T3 (en) Benzoxazines and related nitrogenous heterobicyclic compounds which can be used as mineral corticoid receptor modulators
ATE481405T1 (en) THIAZOLPYRAZOLOPYRIMIDINES AS ANTAGONISTS OF THE CRF1 RECEPTOR
DK1781321T3 (en) METHOD OF TREATING CANCER INCLUDING A VEGF-B ANTAGONIST
MX2009006202A (en) Compositions and methods for treating a neoplasm.
EA201171063A1 (en) PHARMACEUTICAL COMPOSITIONS OF OLMESARTAN